https://techpapersworld.com/wp-content/uploads/2022/07/Vitrolife-AB-publ-Interim-report-1280x720.jpg

Second quarter Sales of SEK 829 (382) million, corresponding to an increase of 117% in SEK, whereof currency effect 18%, acquired growth 80% and organic growth 18%. Consumables increased sales by 24% in SEK, Technologies by 37% in SEK, and Genetic Services contributed sales of SEK 341 million. Strong growth in all market regions. Americas 241%, EMEA 53%, Japan Pacific 85% and Asia 73% in local currencies. Operating income before depreciation and amortisation (EBITDA) was SEK 273 (134) million, corresponding to a...